155 related articles for article (PubMed ID: 29135689)
1. VLDL triglyceride accumulation in skeletal muscle and adipose tissue in type 2 diabetes.
Søndergaard E; Nielsen S
Curr Opin Lipidol; 2018 Feb; 29(1):42-47. PubMed ID: 29135689
[TBL] [Abstract][Full Text] [Related]
2. Increased VLDL-TG Fatty Acid Storage in Skeletal Muscle in Men With Type 2 Diabetes.
Andersen IR; Søndergaard E; Sørensen LP; Nellemann B; Gormsen LC; Jensen MD; Nielsen S
J Clin Endocrinol Metab; 2017 Mar; 102(3):831-839. PubMed ID: 27898284
[TBL] [Abstract][Full Text] [Related]
3. Postprandial VLDL-TG metabolism in type 2 diabetes.
Søndergaard E; Johansen RF; Jensen MD; Nielsen S
Metabolism; 2017 Oct; 75():25-35. PubMed ID: 28964326
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein lipase activity does not predict very low-density lipoprotein-triglyceride fatty acid oxidation during exercise.
Søndergaard E; Andersen IR; Sørensen LP; Gormsen LC; Nielsen S
Scand J Med Sci Sports; 2017 May; 27(5):474-481. PubMed ID: 28207959
[TBL] [Abstract][Full Text] [Related]
5. Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men.
Sørensen LP; Andersen IR; Søndergaard E; Gormsen LC; Schmitz O; Christiansen JS; Nielsen S
Diabetes; 2011 Jan; 60(1):88-96. PubMed ID: 20858686
[TBL] [Abstract][Full Text] [Related]
6. Postabsorptive VLDL-TG fatty acid storage in adipose tissue in lean and obese women.
Nellemann B; Gormsen LC; Christiansen JS; Jensen MD; Nielsen S
Obesity (Silver Spring); 2010 Jul; 18(7):1304-11. PubMed ID: 19875996
[TBL] [Abstract][Full Text] [Related]
7. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice.
Minehira K; Young SG; Villanueva CJ; Yetukuri L; Oresic M; Hellerstein MK; Farese RV; Horton JD; Preitner F; Thorens B; Tappy L
J Lipid Res; 2008 Sep; 49(9):2038-44. PubMed ID: 18515909
[TBL] [Abstract][Full Text] [Related]
8. Myonectin deletion promotes adipose fat storage and reduces liver steatosis.
Little HC; Rodriguez S; Lei X; Tan SY; Stewart AN; Sahagun A; Sarver DC; Wong GW
FASEB J; 2019 Jul; 33(7):8666-8687. PubMed ID: 31002535
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
Takahashi S
J Atheroscler Thromb; 2017 Jun; 24(6):552-559. PubMed ID: 28428482
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance.
Kelley DE; Goodpaster BH
Diabetes Care; 2001 May; 24(5):933-41. PubMed ID: 11347757
[TBL] [Abstract][Full Text] [Related]
11. Muscle triglyceride and insulin resistance.
Kelley DE; Goodpaster BH; Storlien L
Annu Rev Nutr; 2002; 22():325-46. PubMed ID: 12055349
[TBL] [Abstract][Full Text] [Related]
12. The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.
Tan GD; Fielding BA; Currie JM; Humphreys SM; Désage M; Frayn KN; Laville M; Vidal H; Karpe F
Diabetologia; 2005 Jan; 48(1):83-95. PubMed ID: 15619071
[TBL] [Abstract][Full Text] [Related]
13. Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
Chan DC; Gan SK; Wong AT; Barrett PH; Watts GF
Diabetes Obes Metab; 2014 Oct; 16(10):994-1000. PubMed ID: 24821431
[TBL] [Abstract][Full Text] [Related]
14. Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.
Johansen RF; Søndergaard E; Linnebjerg H; Garhyan P; Lam ECQ; Porksen N; Jacober SJ; Nielsen S
Diabetes Obes Metab; 2018 Feb; 20(2):419-426. PubMed ID: 28817248
[TBL] [Abstract][Full Text] [Related]
15. Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism
Beaudry KM; Devries MC
Appl Physiol Nutr Metab; 2019 Aug; 44(8):805-813. PubMed ID: 30702924
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte Proteins and Storage of Endogenous Fatty Acids in Visceral and Subcutaneous Adipose Tissue in Severe Obesity.
Lytle KA; Bush NC; Triay JM; Kellogg TA; Kendrick ML; Swain JM; Gathaiya NW; Hames KC; Jensen MD
Obesity (Silver Spring); 2021 Jun; 29(6):1014-1021. PubMed ID: 33893721
[TBL] [Abstract][Full Text] [Related]
17. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
[TBL] [Abstract][Full Text] [Related]
18. Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation.
Karpe F; Bickerton AS; Hodson L; Fielding BA; Tan GD; Frayn KN
Biochem Soc Trans; 2007 Jun; 35(Pt 3):472-6. PubMed ID: 17511631
[TBL] [Abstract][Full Text] [Related]
19. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy.
Taskinen MR; Beltz WF; Harper I; Fields RM; Schonfeld G; Grundy SM; Howard BV
Diabetes; 1986 Nov; 35(11):1268-77. PubMed ID: 3530855
[TBL] [Abstract][Full Text] [Related]
20. Characterization of stages in development of obesity-diabetes syndrome in sand rat (Psammomys obesus).
Kalderon B; Gutman A; Levy E; Shafrir E; Adler JH
Diabetes; 1986 Jun; 35(6):717-24. PubMed ID: 3519325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
